Financials

  • Market Capitalization 5.59 B
  • Employee 433
  • Founded 2018
  • CEO N/A
  • Website www.mirumpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00MH7T2M7
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-168.06
Rapporto prezzo/fatturato
7.61

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1153
RYTM
Rhythm Pharmaceuticals, Inc. - Common Stock
89.82 USD-1.06%-4.92%-15.11%-18.57%6.18 B USD
1167
IMVT
Immunovant, Inc. - Common Stock
29.48 USD-3.25%-12.03%-20.86%+53.46%6.09 B USD
1247
ERAS
Erasca, Inc. - Common Stock
15.46 USD-3.56%+4.88%-3.19%+557.87%5.41 B USD
1271
PTCT
PTC Therapeutics, Inc. - Common Stock
62.92 USD-2.75%-2.49%-6.09%-3.20%5.25 B USD

Notizie